Guardant buys MetaSight for $59M upfront to acquire blood test tech - aMoon

WE believe
portfolio
alpha
TEAM
IMPACT
news & INSIGHTS

Guardant buys MetaSight for $59M upfront to acquire blood test tech

Guardant buys MetaSight for $59M upfront to acquire blood test tech

Guardant buys MetaSight for $59M upfront to acquire blood test tech

Contact Careers terms of service privacy policy

Ra'anana, Israel

© aMoon Website by nym. Developed by Rabbi Interactive